Abstract
Objective: Chemokine-like receptor 1 (CMKLR1) is expressed by human antigen presenting cells and binds to chemerin, a proteolytically activatable chemoattractant. Here we assessed the expression of mCMKLR1 on mouse leukocytes, focusing on ex vivo dendritic cells (DC) and macrophages. mCMKLR1-expressing cells were evaluated for functional responses to chemerin. We examined the regulation of mCMKLR1 expression by exposure to toll-like receptor (TLR) ligands and cytokines. Finally, we evaluated ex vivo human ascites macrophages for huCMKLR1 expression and chemerin responsiveness. Methods: A novel anti-mCMKLR1 monoclonal antibody was generated to assess mCMKLR1 expression by mouse leukocytes using flow cytometry. Mouse bone marrow-derived DC precursors, mouse peritoneal macrophages, and human ascites leukocytes were examined in functional assays (in vitro chemotaxis and intracellular calcium mobilization). Results: During DC differentiation from bone marrow, mCMKLR1 is upregulated early and then diminishes with time in culture. Most DC in vivo do not detectably express the receptor. In contrast, freshly isolated F4/80+CD11b+ mouse serosal macrophages express mCMKLR1, bind a fluorescently labeled chemerin peptide, and display calcium signaling and migration to the active ligand. Interestingly, macrophage mCMKLR1 is suppressed by proinflammatory cytokines and TLR ligands, whereas treatment with TGF-β upregulates the receptor. A small population of blood-borne F4/80+CD11b+ macrophages also expresses mCMKLR1. Freshly isolated macrophages from human ascites fluid express CMKLR1 and are chemerin responsive, as well. Conclusion: The conserved expression of CMKLR1 by macrophages in mouse and man, coupled with the stimuli-specific regulation of CMKLR1, may reflect a critical role for CMKLR1:chemerin in shaping the nature (either proinflammatory or suppressive) in macrophage-mediated immune responses.
Original language | English |
---|---|
Pages (from-to) | 1106-1114 |
Number of pages | 9 |
Journal | Experimental Hematology |
Volume | 34 |
Issue number | 8 |
DOIs | |
Publication status | Published - Aug 2006 |
Bibliographical note
Funding Information:We thank J. Zabel for helpful discussions. B.A.Z. is supported by National Institutes of Health Training Grant 5 T32 AI07290-15. This work is supported by National Institutes of Health Grants AI-59635, AI-47822, and GM-37734; Specialized Center of Research Grant HL-67674; Digestive Disease Center Grant DK56339; and a Merit Award from the Veterans Administration to E.C.B. S.J.A. is supported by a postdoctoral fellowship from the Cancer Research Institute, New York. T.M.H. is supported by grants from the National Institutes of Health (AI37113-09), the UC Discovery Program (Bio03-10367), and the UC AIDS Program (1D03-B-005). B.J. holds the Canada Research Chair in Inflammation and Immunity and is supported by grants from the National Cancer Institute of Canada/Terry Fox Foundation and Nova Scotia Health Research Foundation.
ASJC Scopus Subject Areas
- Molecular Biology
- Hematology
- Genetics
- Cell Biology
- Cancer Research
PubMed: MeSH publication types
- Journal Article
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
- Research Support, U.S. Gov't, Non-P.H.S.